Filitra at a Glance
Filitra 40 mg is a vardenafil-based phosphodiesterase type-5 (PDE-5) inhibitor formulation manufactured by Fortune Health Care for laboratory research purposes. This compound belongs to the class of selective PDE-5 inhibitors, which function by blocking the enzymatic breakdown of cyclic guanosine monophosphate (cGMP) in cellular models. Researchers at Stroid UK Shop utilise this formulation to investigate vascular smooth muscle relaxation mechanisms and nitric oxide signaling pathways in controlled laboratory environments. The 40mg concentration provides researchers with standardised dosing for comparative studies examining PDE-5 inhibition effects across different experimental conditions.
Laboratory Applications
Research teams investigate Filitra 40mg to examine endothelial function, vascular tone regulation, and cyclic nucleotide signaling cascades in various cellular models. This formulation enables scientists to study the pharmacokinetic properties of vardenafil, including absorption rates, bioavailability markers, and metabolic pathways through in-vitro analysis. Cardiovascular researchers analyse how PDE-5 inhibition affects smooth muscle cell contractility, calcium channel modulation, and nitric oxide-dependent vasodilation responses. The compound serves as a reference standard in studies comparing different PDE-5 inhibitor efficacy profiles and selectivity ratios. Laboratories studying vardenafil-based formulations utilise this preparation to investigate drug-drug interactions, enzymatic inhibition kinetics, and receptor binding affinities in controlled experimental settings.
Technical Specifications
| Active Compound | Vardenafil HCl |
|---|---|
| Concentration | 40mg per tablet |
| Manufacturer | Fortune Health Care |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | Cool, dry conditions below 25°C |
| Research Applications | PDE-5 inhibition studies, vascular research |
Research facilities examining metabolic pathways often cross-reference these studies with investigations into selective androgen receptor modulators and peptide-based compounds to understand comprehensive endocrine and vascular interactions.
Research Compliance
Filitra 40mg Fortune Health Care is manufactured exclusively for in-vitro research applications and laboratory analysis. This product is not intended for human consumption, clinical use, or therapeutic applications. Researchers must maintain appropriate laboratory protocols, storage conditions, and documentation when handling this compound. All studies should be conducted within accredited research facilities by qualified personnel following institutional guidelines and regulatory requirements for research chemical handling and disposal.
